Physician profile
Sherrikee Causey
NPI 1649573783
$3,270.39
in general payments reported to CMS, 2019-2025
16 companies · $1,175 in 2025
The $1,175 reported for 2025 was more than what 83% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $230 · 2022: $467 · 2023: $960 · 2024: $438 · 2025: $1,175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,573.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $762.99 | 2021-2025 | |
| Axsome Therapeutics, INC. | $415.63 | 2023-2025 | Auvelity |
| Neurocrine Biosciences, INC. | $338.25 | 2021-2025 | |
| Vanda Pharmaceuticals INC. | $303.67 | 2025 | Fanapt |
| Janssen Pharmaceuticals, INC | $241.70 | 2023-2025 | Spravato, Invega Sustenna |
| Alkermes, INC. | $226.71 | 2023-2025 | Lybalvi, Aristada, Aristada Initio |
| Teva Pharmaceuticals USA, INC. | $173.31 | 2022-2024 | Uzedy |
| Jazz Pharmaceuticals INC. | $164.88 | 2023 | |
| Avanir Pharmaceuticals, INC. | $154.27 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $143.98 | 2023 | Nuedexta |
| Acadia Pharmaceuticals INC | $119.54 | 2022-2023 | Nuplazid |
| Supernus Pharmaceuticals, INC. | $91.56 | 2025 | Qelbree |
| Inspire Medical Systems, INC. | $82.07 | 2023 | Inspire |
| Alexion Pharmaceuticals, INC. | $20.68 | 2023 | Ultomiris |
| Genzyme Corporation | $16.40 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $14.75 | 2023 | Briviact |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherrikee Causey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.